MCID: DBT087
MIFTS: 58

Diabetes Insipidus, Neurohypophyseal malady

Categories: Genetic diseases, Rare diseases, Endocrine diseases, Nephrological diseases, Neuronal diseases

Aliases & Classifications for Diabetes Insipidus, Neurohypophyseal

About this section
Sources:
2CDC, 11Disease Ontology, 12diseasecard, 13DISEASES, 24GeneTests, 25Genetics Home Reference, 27GTR, 31ICD10 via Orphanet, 37MedGen, 39MeSH, 40MESH via Orphanet, 45NCIt, 48NIH Rare Diseases, 50Novoseek, 52OMIM, 54Orphanet, 62SNOMED-CT, 64The Human Phenotype Ontology, 68UMLS, 69UMLS via Orphanet, 70UniProtKB/Swiss-Prot
See all MalaCards sources

Aliases & Descriptions for Diabetes Insipidus, Neurohypophyseal:

Name: Diabetes Insipidus, Neurohypophyseal 52 25 70 12
Central Diabetes Insipidus 11 48 25 54 50 68
Neurohypophyseal Diabetes Insipidus 11 48 24 25 13
Neurogenic Diabetes Insipidus 48 54 70
Pituitary Diabetes Insipidus 11 48 25
Cdi 54 70 2
Vasopressin Defective Diabetes Insipidus 11 25
Diabetes Insipidus Neurohypophyseal 48 27
Diabetes Insipidus Cranial Type 48 70
 
Diabetes Insipidus, Neurogenic 25 39
Vasopressin Deficiency 11 25
Diabetes Insipidus Secondary to Vasopressin Deficiency 25
Nephrogenic Diabetes Insipidus, Type I 68
Primary Central Diabetes Insipidus 70
Diabetes Insipidus, Pituitary 25
Diabetes Insipidus Neurogenic 48
Diabetes Insipidus, Central 25
Ndi 70

Characteristics:

Orphanet epidemiological data:

54
central diabetes insipidus:
Inheritance: Autosomal dominant,Autosomal recessive,X-linked dominant; Prevalence: 1-9/100000 (Europe); Age of onset: Childhood; Age of death: normal life expectancy

HPO:

64
diabetes insipidus, neurohypophyseal:
Inheritance: autosomal dominant inheritance
Inheritance: x-linked inheritance

Classifications:



External Ids:

OMIM52 125700
Disease Ontology11 DOID:12388
MeSH39 D020790
NCIt45 C84933
Orphanet54 ORPHA178029
ICD10 via Orphanet31 E23.2
MESH via Orphanet40 D020790
UMLS via Orphanet69 C0687720
MedGen37 C0687720

Summaries for Diabetes Insipidus, Neurohypophyseal

About this section
NIH Rare Diseases:48 Central diabetes insipidus (DI) is a form of DI that occurs when the body has lower than normal levels of antidiuretic hormone (vasopressin), which is characterized by frequent urination. Diabetes insipidus is subdivided into central and nephrogenic DI. Two other forms are gestational DI and primary polydipsia (dipsogenic DI). Central DI results from damage to the pituitary gland, which disrupts the normal storage and release of antidiuretic hormone (ADH). When this hormone reaches the kidneys, it directs them to make less urine. The major symptoms of central diabetes insipidus (DI) include urinating too much (polyuria), getting up at night to urinate (nocturia), and drinking too much liquids (polydipsia).  Damage to the pituitary gland can be caused by different diseases as well as by head injuries, neurosurgery, or genetic disorders. The three main options for the treatment of central DI include a synthetic hormone called desmopressin, which can be taken by as an injection, a nasal spray, or a pill; other drugs, such as chlorpropamide, carbamazepine, thiazide diuretics, and nonsteroidal anti-inflammatory drugs; and a low-solute (mostly low-sodium, low-protein) diet. Last updated: 12/27/2016

MalaCards based summary: Diabetes Insipidus, Neurohypophyseal, also known as central diabetes insipidus, is related to diabetes insipidus and hereditary central diabetes insipidus, and has symptoms including diabetes insipidus, weight loss and dehydration. An important gene associated with Diabetes Insipidus, Neurohypophyseal is AVP (Arginine Vasopressin), and among its related pathways are Vasopressin-regulated water reabsorption and Aquaporin-mediated transport. Affiliated tissues include heart, brain and pituitary, and related mouse phenotypes are integument and behavior/neurological.

Genetics Home Reference:25 Neurohypophyseal diabetes insipidus is a disorder of water balance. The body normally balances fluid intake with the excretion of fluid in urine. However, people with neurohypophyseal diabetes insipidus produce too much urine (polyuria), which causes them to be excessively thirsty (polydipsia). Affected people need to urinate frequently, which can disrupt daily activities and sleep.

OMIM:52 Neurohypophyseal diabetes insipidus is an autosomal dominant disorder of free water conservation characterized by... (125700) more...

CDC:2 Indicators for Chronic Disease Surveillance - United States, 2013

UniProtKB/Swiss-Prot:70 Diabetes insipidus, neurohypophyseal: A disease characterized by persistent thirst, polydipsia and polyuria. Affected individuals are apparently normal at birth, but characteristically develop symptoms of vasopressin deficiency during childhood.

Wikipedia:71 Neurogenic diabetes insipidus, more commonly known as central diabetes insipidus, is due to a lack of... more...

Related Diseases for Diabetes Insipidus, Neurohypophyseal

About this section

Diseases related to Diabetes Insipidus, Neurohypophyseal via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 71)
idRelated DiseaseScoreTop Affiliating Genes
1diabetes insipidus29.0GNRH1, POMC, PRL, SOX3
2hereditary central diabetes insipidus12.2
3acquired central diabetes insipidus12.2
4diabetes insipidus, nephrogenic11.0
5chromosome xq28 duplication syndrome10.4AVP, AVPR2
6cataract 29, coralliform10.4AQP2, AVP
7seminoma10.3AVP, POMC
8trichuriasis10.3AVP, POMC
9cervical alveolar soft part sarcoma10.3AVP, POMC
10seminal vesicle chronic gonorrhea10.3AVP, POMC
11brain sarcoma10.3AVP, PRL
12synchronous bilateral breast carcinoma10.3AVP, POMC
13aneurysm or dilatation of ascending aorta10.2POMC, PRL
14lactic acidosis10.2POMC, PRL
15colloid carcinoma of the pancreas10.2POMC, PRL
16central retinal vein occlusion10.2POMC, PRL
17acute myeloid leukemia, kit-related10.2POMC, PRL
18hypothryoidism, congenital, nongoitrous 410.2POMC, PRL
19osseous heteroplasia, progressive10.2POMC, PRL
20cold-induced sweating syndrome 210.2POMC, PRL
21aortic valve atresia10.2PRL, SOX3
22lipoadenoma10.2POMC, PRL
23central nervous system angiosarcoma10.2AQP2, POMC
24acute myocarditis10.2POMC, PRL
25loeffler endocarditis10.2POMC, PRL
26nasopharyngeal disease10.2POMC, PRL
27gestational diabetes10.1AQP2, AVP, AVPR2
28cardiovascular organ benign neoplasm10.1POMC, PRL
29myoclonic cerebellar dyssynergia10.1POMC, PRL
30central nervous system hemangioma10.1POMC, PRL
31vestibular gland benign neoplasm10.1POMC, PRL
32skull base neoplasm10.0POMC, PRL
33chronic salpingo-oophoritis10.0POMC, PRL
34benign prostate phyllodes tumor10.0GNRH1, PRL
35epileptic encephalopathy, early infantile, 2610.0AVPR2, GNRH1
36bardet-biedl syndrome10.0AVP, POMC, PRL
37male reproductive organ benign neoplasm10.0POMC, PRL
38immune system organ benign neoplasm10.0AVP, POMC, PRL
39congenital epulis10.0AVP, POMC, PRL
40alveoli adenoma9.9POMC, PRL
41pleural empyema9.9GNRH1, PRL
42peritoneal mesothelioma9.9GNRH1, POMC
43avoidant personality disorder9.9POMC, PRL
44lymphadenitis9.8GNRH1, POMC
45gender identity disorder9.8GNRH1, PRL
46prolactin producing pituitary tumor9.8GNRH1, PRL
47postpartum depression9.7LNPEP, POMC, PRL
48carotid artery disease9.7AQP2, AVP, AVPR2, POMC
49survival motor neuron spinal muscular atrophy9.6POMC, PRL
50pseudopterygium9.6GNRH1, PRL

Graphical network of the top 20 diseases related to Diabetes Insipidus, Neurohypophyseal:



Diseases related to diabetes insipidus, neurohypophyseal

Symptoms & Phenotypes for Diabetes Insipidus, Neurohypophyseal

About this section

Symptoms by clinical synopsis from OMIM:

125700

Clinical features from OMIM:

125700

Human phenotypes related to Diabetes Insipidus, Neurohypophyseal:

 64 54 (show all 35)
id Description HPO Frequency Orphanet Frequency HPO Source Accession
1 diabetes insipidus64 54 hallmark (90%) Very frequent (99-80%) HP:0000873
2 weight loss64 54 hallmark (90%) Very frequent (99-80%) HP:0001824
3 dehydration64 54 hallmark (90%) Very frequent (99-80%) HP:0001944
4 abnormal renal physiology64 hallmark (90%) HP:0012211
5 behavioral abnormality64 typical (50%) HP:0000708
6 migraine64 typical (50%) HP:0002076
7 abnormality of temperature regulation64 typical (50%) HP:0004370
8 reduced consciousness/confusion64 typical (50%) HP:0004372
9 seizures64 54 occasional (7.5%) Occasional (29-5%) HP:0001250
10 diarrhea64 54 occasional (7.5%) Occasional (29-5%) HP:0002014
11 nausea and vomiting64 54 occasional (7.5%) Occasional (29-5%) HP:0002017
12 hyponatremia64 54 occasional (7.5%) Occasional (29-5%) HP:0002902
13 hypernatremia64 occasional (7.5%) HP:0003228
14 hypertelorism64 HP:0000316
15 long philtrum64 HP:0000343
16 wide nose64 HP:0000445
17 central diabetes insipidus64 HP:0000863
18 osteopenia64 HP:0000938
19 abnormality of metabolism/homeostasis64 HP:0001939
20 gliosis64 HP:0002171
21 short nose64 HP:0003196
22 polyuria64 HP:0000103
23 hydronephrosis64 HP:0000126
24 alkalosis64 HP:0001948
25 polydipsia64 54 Very frequent (99-80%) HP:0001959
26 hypokalemia64 HP:0002900
27 nocturia54 Very frequent (99-80%)
28 depression54 Frequent (79-30%)
29 anxiety54 Frequent (79-30%)
30 lethargy54 Frequent (79-30%)
31 somnolence54 Frequent (79-30%)
32 failure to thrive54 Very frequent (99-80%)
33 fever54 Frequent (79-30%)
34 anorexia54 Very frequent (99-80%)
35 headache54 Frequent (79-30%)

UMLS symptoms related to Diabetes Insipidus, Neurohypophyseal:


constipation, polyuria, seizures, vomiting, polydipsia

MGI Mouse Phenotypes related to Diabetes Insipidus, Neurohypophyseal according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00107718.6AQP2, AVPR2, GNRH1, POMC, PRL
2MP:00053868.0AQP2, AVP, AVPR2, LNPEP, POMC, PRL
3MP:00053678.0AQP2, AVP, AVPR2, GNRH1, POMC
4MP:00053767.2AQP2, AVP, AVPR2, GNRH1, LNPEP, POMC

Drugs & Therapeutics for Diabetes Insipidus, Neurohypophyseal

About this section

Drugs for Diabetes Insipidus, Neurohypophyseal (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 312)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
TolvaptanapprovedPhase 4, Phase 2, Phase 3, Phase 189150683-30-0216237
Synonyms:
( -)-4'-((7-Chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl)carbonyl)-o-tolu-m-toluidide
150683-30-0
7-Chloro-5-hydroxy-1-(2-methyl-4-(2-methylbenzoylamino)benzoyl)2,3,4,5-tetrahydro-1H-1-benzazepine
AC1L50C9
C116664
CHEBI:327437
CHEMBL344159
CID216237
 
L001628
N-[4-(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)-3-methylphenyl]-2-methylbenzamide
OPC 41061
OPC-41061
PDSP1_001738
PDSP2_001721
Samsca
Tolvaptan
UNII-21G72T1950
benzazepine derivative, 32
2
ZincapprovedPhase 422317440-66-632051, 23994
Synonyms:
30Zn
Cinc
Zinc
Zinc ion
 
Zincum
Zink
Zn
Zn(ii)
Zn2+
3
NorepinephrineapprovedPhase 4, Phase 3, Phase 268351-41-2439260
Synonyms:
(-)-(R)-Norepinephrine
(-)-Arterenol
(-)-Arterenol free base
(-)-NORADRENALINE
(-)-Noradrenaline
(-)-Norepinephrine
(-)-alpha-(Aminomethyl)protocatechuyl alcohol
(R)-(-)-Norepinephrine
(R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol
(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol
(R)-Noradrenaline
(R)-Norepinephrine
1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)- (9CI)
4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol
4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol
4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol
4899-05-2
51-40-1 (l-tartrate (1:1))
51-41-2
66197-73-7
A7257_SIGMA
AC1L96ZT
ALBB-006229
Adrenor
Aktamin
Arterenol
BRN 4231961
BSPBio_002079
C00547
CHEBI:18357
CHEMBL1437
CID439260
D-(-)-Noradrenaline
D00076
D53D5E3A-2360-4CA9-8031-6C2CD4062FD5
DB00368
DivK1c_000230
EINECS 200-096-6
HMS1920B08
HMS2089E18
HMS2091J08
HMS500L12
IDI1_000230
KBio1_000230
KBio2_001489
KBio2_004057
KBio2_006625
KBio3_001579
KBioGR_000635
KBioSS_001489
L-2-Amino-1-(3,4-dihydroxyphenyl)ethanol
L-3,4-Dihydroxyphenylethanolamine
L-3,4-dihydroxyphenylethanolamine
L-Arterenol
L-Noradrenaline
L-Norepinephrine
L-alpha-(Aminomethyl)-3,4-dihydroxybenzyl alcohol
L-alpha-(aminomethyl)-3,4-dihydroxybenzyl alcohol
L-arterenol
L-noradrenaline
LS-42676
LT03330026
 
LT4
Levarterenol
Levarterenolo
Levarterenolo [DCIT]
Levoarterenol
Levonor
Levonoradrenaline
Levonorepinephrine
Levophed
NCGC00159406-02
NCGC00159406-03
NCGC00159406-04
NCGC00159406-05
NCGC00159406-06
NCGC00159406-07
NCGC00159406-09
NINDS_000230
Nor adrenalin
Nor adrenalin (TN)
Nor-Epirenan
Nor-adrenaline
Noradrenalin
Noradrenalina
Noradrenalina [Italian]
Noradrenaline
Noradrenaline (JP15)
Noradrenalinum
Norartrinal
Noreinefrina
Noreinefrina [INN-Spanish]
Norepinefrina
Norepinephrine
Norepinephrine (INN)
Norepinephrine Noradrenalin
Norepinephrine [INN:JAN]
Norepinephrine l-Tartrate (1:1)
Norepinephrinum
Norepinephrinum [INN-Latin]
Norepirenamine
PDSP1_001111
PDSP2_001095
SGCUT00123
SPBio_001048
SPECTRUM1500436
STK503776
Spectrum2_001064
Spectrum3_000520
Spectrum4_000078
Spectrum5_001068
Spectrum_001009
Sympathin E
UNII-X4W3ENH1CV
bmse000404
l-1-(3,4-Dihydroxyphenyl)-2-aminoethanol
l-2-Amino-1-(3,4-dihydroxyphenyl)ethanol
nchembio.284-comp2
nchembio.64-comp2
nchembio705-1
noradrenaline
norepinefrina
norepinephrine
norepinephrinum
to_000024
4
BenzocaineapprovedPhase 4, Phase 218921994-09-7, 94-09-72337
Synonyms:
(p-(Ethoxycarbonyl)phenylamine
06952_FLUKA
112909_ALDRICH
112909_SIAL
1333-08-0
23239-88-5
23239-88-5 (hydrochloride)
4 Aminobenzoic Acid Ethyl Ester
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-14-00-01129 (Beilstein Handbook Reference)
4-Aminobenzoate
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Aminobenzoic acid, ethyl ester
4-Carbethoxyaniline
4-amino-benzoic acid ethyl ester
4-aminobenzoic acid ethyl ester
71123-91-6
94-09-7
94-09-7 (Parent)
A0271
AB00051923
AC1L1DGC
AC1Q341A
AC1Q64JE
AE-562/40377256
AI3-02081
AKOS000119763
AR-1H9065
Acetate, Benzocaine
Aethoform
Aethylium paraminobenzoicum
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthesinum
Anaesthin
Anestezin
Anestezin [Russian]
Anesthesin
Anesthesine
Anesthone
BB_SC-0019
BPBio1_001017
BRD-K75466013-001-05-2
BRN 0638434
BSPBio_000923
BSPBio_001908
Baby Anbesol
Bensokain
Benzoak
Benzocaina
Benzocaina [INN-Spanish]
Benzocaine
Benzocaine (USP/INN)
Benzocaine Acetate
Benzocaine Formate
Benzocaine Hydrobromide
Benzocaine Hydrochloride
Benzocaine Methanesulfonate
Benzocaine [INN:BAN]
Benzocainum
Benzocainum [INN-Latin]
Benzoic acid, 4-amino-, ethyl ester
Benzoic acid, 4-amino-, ethyl ester, hydrochloride
Benzoic acid, amino-, ethyl ester
Benzoic acid, p-amino-, ethyl ester
C07527
CAS-94-09-7
CHEBI:116735
CHEMBL278172
CID2337
Caswell No. 430A
Chloraseptic
D001566
D00552
DB01086
Dermoplast
Diet Ayds
DivK1c_000932
E1501_SIGMA
EINECS 202-303-5
EPA Pesticide Chemical Code 097001
ETHYL-P-AMINOBENZOATE
Ethoform
Ethoforme
Ethyl 4-aminobenzoate
Ethyl 4-aminobenzoate hydrochloride
Ethyl 4-aminobenzoic acid
Ethyl Aminobenzoate
Ethyl PABA
 
Ethyl aminobenzoate
Ethyl aminobenzoate (JP15)
Ethyl aminobenzoate (VAN)
Ethyl aminobenzoic acid
Ethyl p-Aminobenzoate
Ethyl p-Aminophenylcarboxylate
Ethyl p-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethylester kyseliny p-aminobenzoove
Ethylester kyseliny p-aminobenzoove [Czech]
Ethylis aminobenzoas
Formate, Benzocaine
HMS1570O05
HMS1920G09
HMS2091M11
HMS502O14
HSDB 7225
Hurricaine
Hydrobromide, Benzocaine
Hydrochloride, Benzocaine
I05-0204
IDI1_000932
Identhesin
KBio1_000932
KBio2_000474
KBio2_003042
KBio2_005610
KBio3_001408
KBioGR_000658
KBioSS_000474
Keloform
LS-35847
MLS001331704
MLS002153970
Methanesulfonate, Benzocaine
MolPort-000-871-526
NCGC00016352-01
NCGC00094598-01
NCGC00094598-02
NINDS_000932
NSC 122792
NSC 41531
NSC41531
NSC4688
Norcain
Norcaine
Norcainum
Oprea1_750694
Oprea1_827402
Ora-jel
Orabase-B
Orthesin
Otocain
Outgro
Parathesin
Parathesin (TN)
Parathesine
Prestwick0_000712
Prestwick1_000712
Prestwick2_000712
Prestwick3_000712
Prestwick_991
SMR000059025
SPBio_000134
SPBio_002844
SPECTRUM1500139
STK043620
Slim Mint Gum
Solarcaine
Solu H
Spectrum2_000117
Spectrum3_000314
Spectrum4_000249
Spectrum5_000860
Spectrum_000074
Topcaine
UNII-U3RSY48JW5
WLN: ZR DVO2
ZINC12358719
benzocaine
ethylaminobenzoate-4
h-4-abz-oet
nchembio.182-comp4
p-(Ethoxycarbonyl)aniline
p-Aminobenzoate
p-Aminobenzoic acid
p-Aminobenzoic acid ethyl ester
p-Aminobenzoic acid, ethyl ester
p-Aminobenzoic ethyl ester
p-Carbethoxyaniline
p-Ethoxycarboxylic Aniline
p-Ethoxycarboxylic aniline
5
Conivaptanapproved, investigationalPhase 4, Phase 3, Phase 2, Phase 121210101-16-9151171
Synonyms:
210101-16-9
4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide
4'-((4,5-dihydro-2-methylimidazo(4,5-d)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide
AC1L45SX
CHEBI:681850
CHEMBL1755
CID151171
Conivaptan
Conivaptan (INN)
Conivaptan [INN]
D07748
DB00872
 
I14-8805
L001073
L001531
LS-187117
MolPort-005-940-873
N-[4-(2-methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenylbenzamide
N-{4-[(2-methyl-4,5-dihydroimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl}biphenyl-2-carboxamide
PDSP1_001735
PDSP2_001718
UNII-0NJ98Y462X
YM 087
YM-087
YM087
ZINC12503187
6
Epinephrineapproved, vet_approvedPhase 4, Phase 3, Phase 2, Phase 193351-43-45816
Synonyms:
(-)-(R)-Epinephrine
(-)-3,4-Dihydroxy-a-[2-(methylamino)ethyl]benzyl alcohol
(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol
(-)-3,4-Dihydroxy-alpha-[2-(methylamino)ethyl]benzyl alcohol
(-)-3,4-dihydroxy-a-[(methylamino)methyl]-Benzyl alcohol
(-)-3,4-dihydroxy-alpha-[(methylamino)methyl]-Benzyl alcohol
(-)-Adrenalin
(-)-Adrenaline
(-)-Epinephrine
(-)-R-Epinephrine
(R)-(-)-Adnephrine
(R)-(-)-Adrenaline
(R)-(-)-Epinephrine
(R)-(-)-Epirenamine
(R)-(−)-adrenaline
(R)-4-[1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
(R)-4-[1-hydroxy-2-(methylamino)ethyl]-1,2-Benzenediol
(R)-Adrenaline
(R)-Epinephrine
(−)-adrenaline
02252_FLUKA
1-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
1-Adrenalin
1-Epinephrine
4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol
4-(1-hydroxy-2-methylamino-ethyl)benzene-1,2-diol
4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-Benzenediol
4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
51-43-4
51-43-4 (FREE BASE)
51028-73-0
A0173
AC-13188
AC1L1L7B
ADR ADRENALINE
ADROP
AI3-19015
Adnephrine
Adrenal
Adrenalin
Adrenalin (TN)
Adrenalin in Oil
Adrenalin-Medihaler
Adrenalina
Adrenalina [DCIT]
Adrenaline
Adrenaline (JP15)
Adrenaline/Epinephrine
Adrenalinum
Adrenamine
Adrenan
Adrenapax
Adrenasol
Adrenatrate
Adrenine
Adrenodis
Adrenohorma
Adrenosan
Adrenutol
Adrin
Adrine
Ana-Guard
Ana-Kit
Antiasthmatique
Asmatane Mist
Asthma meter mist
Asthma-nefrin
Asthmahaler Mist
Asthmanefrin
Astmahalin
Astminhal
BIDD:GT0119
Balmadren
Bernarenin
Biorenine
Bosmin
Brevirenin
Bronkaid
Bronkaid Mist
Bronkaid Suspension Mist
Bupivacaine Hcl and Epinephrine
C00788
CCRIS 4812
CHEBI:28918
CHEMBL679
CID5816
Chelafrin
Citanest Forte
Corisol
D-Epifrin
D-Epinephrine
D00095
DB00668
Drenamist
Dylephrin
Dyspne-Inhal
E4250_SIGMA
EINECS 200-098-7
EPI E Z PEN JR
EPIPEN E Z PEN
EPIPEN JR
Epi EZ Pen Jr
Epifrin
Epiglaufrin
Epinefrin
Epinefrin [Czech]
Epinefrina
Epinefrina [INN-Spanish]
Epinephran
Epinephrin
Epinephrine
Epinephrine (USP)
Epinephrine (USP/INN)
Epinephrine [USAN:INN:JAN]
Epinephrine hydrochloride
Epinephrinum
Epinephrinum [INN-Latin]
Epipen
Epipen (TN)
Epipen Auto-Injector
Epipen EZ Pen
Epipen Jr.
Epipen Jr. Auto-Injector
Epirenamine
Epirenan
Epirenin
Epitrate
Eppy
Esphygmogenina
Exadrin
 
Glaucon
Glaucosan
Glauposine
Glycirenan
HSCI1_000215
HSDB 4289
Haemostasin
Haemostatin
Hektalin
Hemisine
Hemostasin
Hemostatin
Hypernephrin
Hyporenin
IOP
Intranefrin
Iontocaine
Isoptoepinal
Kidoline
L-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
L-Adrenaline
L-Adrenaline Base
L-Epinehphrine
L-Epinephrine
L-Epirenamine
L-Methylaminoethanolcatechol
L-epinephrine
LS-156
Levo-Methylaminoethanolcatechol
Levoadrenaline
Levoepinephrine
Levorenen
Levorenin
Levorenine
Levoreninum
Lopac-E-4642
Lyodrin
Lyophrin
Medihaler-Epi
Metanephrin
Methylaminoethanolcatechol
Methylarterenol
Micronefrin
Micronephrine
MolPort-002-051-368
Mucidrina
Myosthenine
Mytrate
NCGC00015417-01
NCGC00142615-01
NCGC00142615-03
NCGC00142615-04
NCGC00142615-05
NCGC00142615-06
NCGC00142615-07
NSC 62786
NSC62786
Nephridine
Nieraline
PDSP1_001120
PDSP2_001104
Paranephrin
Primatene
Primatene Mist
R-(-)-Epinephrine
R-Adrenaline
RCRA waste no. P042
Racemic Epinephrine
Racepinephrine
Rcra waste number P042
Renagladin
Renaglandin
Renaglandulin
Renaleptine
Renalina
Renoform
Renostypricin
Renostypticin
Renostyptin
SMP1_000227
ST069368
SUS-PHRINE SULFITE-FREE
Scurenaline
Septocaine
Simplene
Sindrenina
Soladren
Sphygmogenin
Stryptirenal
Styptirenal
Supracapsulin
Supradin
Supranefran
Supranephrane
Supranephrine
Supranol
Suprarenaline
Suprarenin
Suprel
Surenine
Surrenine
Sus-Phrine
Sus-phrine
Susphrine
Sympathin I
Takamina
Takamine
Tokamina
Tonogen
Twinject
Twinject 0.15
Twinject 0.3
Twinject 0.30
UNII-YKH834O4BH
Vaponefrin
Vasoconstrictine
Vasoconstrictor
Vasodrine
Vasoton
Vasotonin
adrenaline
bmse000316
d-Adrenaline
epinephrine
l-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
l-Adrenalin
l-Adrenaline
l-Epinephine
l-Epinephrine (synthetic)
l-Epirenamine
l-Methylaminoethanolcatechol
levoepinephrine
nchembio747-comp9
7
Furosemideapproved, vet_approvedPhase 4, Phase 3, Phase 2, Phase 118854-31-93440
Synonyms:
2-Furfurylamino-4-chloro-5-sulfamoylbenzoic acid
4-Chloro-5-sulfamoyl-N-furfuryl-anthranilic acid
4-Chloro-N-(2-furylmethyl)-5-sulfamoylanthranilic acid
4-Chloro-N-furfuryl-5-sulfamoylanthranilic acid
4-chloro-2-(furan-2-ylmethylamino)-5-sulfamoylbenzoic acid
4-chloro-2-[(furan-2-ylmethyl)amino]-5-sulfamoylbenzoic acid
41733-55-5 (mono-hydrochloride salt)
5-18-09-00555 (Beilstein Handbook Reference)
54-31-9
AB00052001
AC-11067
AC1L1FXW
AC1Q557O
AKOS000266625
ARONIS24304
Acetic acid potassium salt
Aisemide
Aldalix
Aldic
Aluzine
Anfuramaide
Apo-Frusemide
Apo-Furosemide
Aquarid
Aquasin
Arasemide
BIDD:GT0139
BPBio1_000443
BRD-K78010432-001-05-8
BRN 0840915
BSPBio_000401
BSPBio_002054
Beronald
Bio-0044
Bioretic
Bristab
Bristurin
C12H11ClN2O5S
CAS-54-31-9
CCRIS 1951
CHEBI:47426
CHEMBL35
CID3440
CPD000058202
Cetasix
Chlor-N-(2-furylmethyl)-5-sulfamylanthranilsaeure
Chlor-N-(2-furylmethyl)-5-sulfamylanthranilsaeure [German]
D00331
D005665
DB00695
DB07799
Depix
Desal
Desdemin
Di-Ademil
Dihydroflumethiazide
Dirine
Disal
Discoid
Disemide
Diucardin
Diumide-K
Diural
Diurapid
Diuretic Salt
Diuretic salt
Diurin
Diurolasa
Diusemide
Diusil
Diuzol
DivK1c_000575
Dranex
Dryptal
Durafurid
EINECS 200-203-6
Edemid
Edenol
Eliur
Elodrine
Endural
Errolon
Eutensin
F0182
F4381_SIGMA
FUN
FUROSEMIDE USP
Farsix
Finuret
Fluidrol
Fluss
Franyl
Frumex
Frumide
Frumil
Frusedan
Frusema
Frusemid
Frusemide
Frusemin
Frusenex
Frusetic
Frusid
Fu sid
Fulsix
Fuluvamide
Fuluvamine
Furanthril
Furanthryl
Furantral
Furantril
Furanturil
Furesis
Furetic
Furex
Furfan
Furix
Furmid
Furo-Basan
Furo-Puren
Furo-puren
Furobeta
Furocot
Furodiurol
Furodrix
Furomen
Furomex
Furomide M.D
Furomide M.D.
Furorese
Furosan
Furose
Furosedon
Furosemid
Furosemida
Furosemida [INN-Spanish]
Furosemide
Furosemide "mita"
Furosemide (JP15/USP/INN)
Furosemide Monohydrochloride
Furosemide Monosodium Salt
Furosemide [USAN:INN:JAN]
Furosemidu
Furosemidu [Polish]
Furosemidum
Furosemidum [INN-Latin]
Furosemix
Furoside
Furosifar
Furosix
Furoter
Furovite
Fursemid
Fursemida
Fursemide
Fursol
Fusid
Fusidic acid
 
Golan
HMS1569E03
HMS1920B03
HMS2090K06
HMS2091H05
HMS501M17
HSDB 3086
Hissuflux
Hoe-058A
Hydol
Hydrenox
Hydrex
Hydro
Hydro-Rapid
Hydro-rapid
Hydroled
I04-0179
IDI1_000575
Impugan
Jenafusid
KBio1_000575
KBio2_001580
KBio2_004148
KBio2_006716
KBio3_001274
KBioGR_001259
KBioSS_001580
Katlex
Kofuzon
Kolkin
Kutrix
LB 502
LB-502
LS-204
Lasemid
Lasex
Lasiletten
Lasilix
Lasix
Lasix (TN)
Lasix (tn)
Lasix Retard
Lasix Special
Lasix, Frusemide, Furosemide
Laxur
Lazix
Leodrine
Less Diur
Liside
Logirene
Lowpston
Lowpstron
Luscek
MLS001066374
MLS001306403
Macasirool
Marsemide
Metflorylthiazidine
Methforylthiazidine
Mirfat
Mita
Moilarorin
MolPort-001-641-065
Myrosemide
NCGC00016241-01
NCGC00090893-01
NCGC00090893-02
NCGC00090893-03
NCGC00090893-05
NCGC00090893-06
NCI-C55936
NINDS_000575
NSC 269420
NSC269420
Nadis
Nelsix
Neo-Renal
Neo-renal
Nephron
Nicorol
Novosemide
Octan Draselny
Octan draselny
Odemase
Odemex
Oedemex
Olmagran
Oprea1_667724
Osyrol
Polysquall A
Prefemin
Prestwick0_000341
Prestwick1_000341
Prestwick2_000341
Prestwick3_000341
Prestwick_752
Profemin
Promedes
Promide
Protargen
Puresis
Radisemide
Radonna
Radouna
Retep
Rodiuran
Rontyl
Rosemide
Rosis
Rusyde
S1603_Selleck
SAM002264614
SMP1_000129
SMR000058202
SPBio_001129
SPBio_002322
SPECTRUM1500310
STK177334
Sal Diureticum
Sal diureticum
Salinex
Salix
Salix (brand of furosemide)
Salurex
Salurid
Saluron
Seguril
Selectofur
Sigasalur
Sisuril
Spectrum2_001005
Spectrum3_000437
Spectrum4_000560
Spectrum5_000744
Spectrum_001100
Spirofur
Synephron
TL8003563
Transit
Trofurit
UNII-7LXU5N7ZO5
UPCMLD-DP022
UPCMLD-DP022:001
Uremide
Uresix
Urex
Urex-M
Urian
Uridon
Uritol
Urosemide
Vergonil
Vesix
WLN: T5OJ B1MR CG FVQ DSZW
Yidoli
Zafimida
fulvamide
furosemide
furosemide ''mita''
less Diur
8
MisoprostolapprovedPhase 428659122-46-25282381
Synonyms:
(+/-)-15-Deoxy-(16RS)-16-hydroxy-16-methylprostaglandin E1 methyl ester
(11-alpha,13E)-(+-)-11,16-Dihydroxy-16-methyl-9-oxoprost-13-en-1-oic acid methyl ester
59122-46-2
62015-39-8
AC1NQZZA
Ambap103601-27-0
BRN 4155643
CCRIS 6859
CHEMBL606
CID5282381
Cytotec
Cytotec (TN)
D00419
DB00929
GyMiso
HMS2090L10
HSDB 3573
I14-11712
Isprelor
 
M6807_SIGMA
MLS000028863
Methyl (+-)-11-alpha,16-dihydroxy-16-methyl-9-oxoprost-13-en-1-oate
Misopess
Misoprostol (JAN/USAN/INN)
Misoprostolum
Misoprostolum [INN-Latin]
Misotol
MolPort-003-666-830
NCGC00162445-01
NCGC00162445-02
SC 29333
SC-29333
SMP1_000193
SMR000058558
UNII-0E43V0BB57
XP-16J
methyl (11alpha,13E)-11,16-dihydroxy-16-methyl-9-oxoprost-13-en-1-oate
methyl 7-[(1R,2R,3R)-3-hydroxy-2-[(E)-4-hydroxy-4-methyloct-1-enyl]-5-oxocyclopentyl]heptanoate
misoprostol
9
OxymetazolineapprovedPhase 4, Phase 24401491-59-44636
Synonyms:
1491-59-4
2-(4-Tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline
2-(4-tert-Butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline
3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethyl-6-tert-butyl-phenol
3-[(4,5-Dihydro-1H-imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol
3-[(4,5-dihydro-1H-Imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol
6-Tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol
6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol
6-tert-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol
6-tert-Butyl-3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethylphenol
AC-6370
AC1L1IM1
Afrin Cherry 12 Hour Nasal Spray
Afrin Extra Moisturizing 12 Hour Nasal Spray
Afrin Original 12 Hour Nasal Spray
Afrin Original 12 Hour Nose Drops
Afrin Original 12 Hour Pump Mist
Afrin Sinus 12 Hour Nasal Spray
BPBio1_000295
BPBio1_000419
BRD-K16195444-001-01-7
BRN 0886303
BSPBio_000267
BSPBio_002145
Biomol-NT_000161
C07363
CAS-151615
CHEBI:142520
CHEMBL762
CID4636
D010109
D08322
DB00935
DivK1c_000567
Dristan Long Lasting Mentholated Nasal Spray
Dristan Long Lasting Nasal Mist
Drixoral Nasal Solution
Duramist Plus Up To 12 Hour Nasal Decongestant Spray
EINECS 216-079-1
FT-0082560
Genasal Nasal Spray Up to 12 Hour Relief
H 990
HMS2089G03
HSDB 3143
Hazol
IDI1_000567
Iliadin
KBio1_000567
KBio2_001531
KBio2_004099
KBio2_006667
KBio3_001645
KBioGR_000908
KBioSS_001531
L000459
LS-104146
 
Lopac-O-2378
Lopac0_000903
MolPort-002-538-313
NCGC00015766-01
NCGC00015766-02
NCGC00015766-03
NCGC00015766-10
NCGC00022345-02
NCGC00022345-04
NCGC00022345-05
NCGC00022345-06
NINDS_000567
Nafrine
Nasal Relief 12 Hour Nasal Spray
Navasin
Navisin
Neo-Synephrine 12 Hour Spray
Nezeril
Nostrilla 12 Hour Nasal Decongestant
Operil (TN)
Oximetazolina
Oximetazolina [INN-Spanish]
Oximetazolinum
Oxylazine
Oxymetazolina
Oxymetazoline (INN)
Oxymetazoline [INN:BAN]
Oxymetazoline hydrochloride crystalline
Oxymetazolinum
Oxymetazolinum [INN-Latin]
Oxymethazoline
Oxymetozoline
Phenol, 3-[(4,5-dihydro-1H-imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethyl- (9CI)
Phenol, 6-tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethyl- (7CI,8CI)
Prestwick0_000224
Prestwick1_000224
Prestwick2_000224
Prestwick3_000224
Rhinofrenol
Rhinolitan
SPBio_001095
SPBio_002188
Sinerol
Spectrum2_000998
Spectrum3_000533
Spectrum4_000464
Spectrum5_001114
Spectrum_001051
Tocris-1142
UNII-8VLN5B44ZY
Vicks Sinex 12 Hour Nasal Spray
Vicks Sinex 12 Hour Ultra Fine Mist for Sinus Relief
Visine L.R
Visine L.R.
nchembio705-11
oxymeta zoline
oxymetazoline
oxymetazoline hydrochloride crystalline
10
Chlorothiazideapproved, vet_approvedPhase 4758-94-62720
Synonyms:
2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-, 1,1-dioxide
58-94-6
6-Chloro-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[1,2,4]thiadiazine-7-sulfonic acid amide
6-Chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
6-Chloro-7-sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide
6-chloro-4H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
6-chloro-7-Sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide
AC-18732
AC1L1EBB
Aldoclor
Alurene
BIDD:GT0635
BPBio1_000070
BRD-K88682005-001-05-9
BSPBio_000062
BSPBio_002003
C 4911
C07461
C2259
C4911_SIGMA
C7H6ClN3O4S2
CAS-58-94-6
CCRIS 5999
CHEBI:3640
CHEMBL842
CID2720
CPD000058429
Chloriazid
Chlorosal
Chlorothiazid
Chlorothiazide
Chlorothiazide (JAN/USP/INN)
Chlorothiazide [USAN:INN:BAN]
Chlorothiazidum
Chlorothiazidum [INN-Latin]
Chlorthiazid
Chlorthiazide
Chlorthiazidum
Chlortiazid
Chlorurit
Chlotride
Chlrosal
Clorotiazida
Clorotiazida [INN-Spanish]
Clorotiazide
Clorotiazide [DCIT]
Clotride
D002740
D00519
DB00880
Diupres
Diuresal
Diuril
Diuril (TN)
Diuril Boluses
Diuril Boluses, Veterinary
Diuril, Chlotride, Chlorothiazide
Diurilix
Diurite
Diutrid
DivK1c_000675
EINECS 200-404-9
EU-0100254
Flumen
HMS1568D04
 
HMS1920K15
HMS2091C18
HMS502B17
HSDB 3030
I06-2278
IDI1_000675
KBio1_000675
KBio2_000594
KBio2_003162
KBio2_005730
KBio3_001223
KBioGR_000780
KBioSS_000594
LS-244
Lopac-C-4911
Lopac0_000254
MLS000028398
Mechlozid
Minzil
MolPort-003-666-143
MolPort-003-845-912
NCGC00015242-01
NCGC00015242-02
NCGC00015242-03
NCGC00015242-05
NCGC00015242-09
NCGC00091042-01
NCGC00091042-02
NCGC00091042-03
NCGC00091042-04
NCGC00091042-05
NINDS_000675
NSC 25693
NSC25693
Neo-Dema
Prestwick0_000251
Prestwick1_000251
Prestwick2_000251
Prestwick3_000251
Prestwick_56
S1641_Selleck
SAM002554891
SMR000058429
SPBio_000288
SPBio_002281
SPECTRUM1500180
Salisan
Salunil
Saluretil
Saluric
Sk-chlorothiazide
Spectrum2_000154
Spectrum3_000342
Spectrum4_000280
Spectrum5_001446
Spectrum_000134
Thiazide
UNII-77W477J15H
Urinex
Uroflux
WLN: T66 BSWM ENJ HG ISZW
Warduzide
Yadalan
chlorothiazide
chlorotiazida
component of Aldoclor
11
Hydrocortisoneapproved, vet_approvedPhase 4, Phase 3, Phase 264050-23-75754, 657311
Synonyms:
(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione
(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione
11-Hydrocortisone
11-beta-Hydrocortisone
11-beta-Hydroxycortisone
11a-Hydroxycorticosterone
11alpha-Hydroxycorticosterone
11b,17,21-Trihydroxyprogesterone
11b-Hydrocortisone
11b-Hydroxycortisone
11beta,17,21-Trihydroxyprogesterone
11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione
11beta-Hydrocortisone
11beta-Hydroxycortisone
11beta-hydrocortisone
11β-hydrocortisone
17-Hydroxycorticosterone
17a-Hydroxycorticosterone
17alpha-Hydroxycorticosterone
2v95
4-Pregnen-11beta,17alpha,21-triol-3,20-dione
4-Pregnene-11alpha,21-triol 3,20-dione
4-Pregnene-11b,17a,21-triol-3,20-dione
50-23-7
8056-08-4
80562-38-5
8063-42-1
AC-12902
AC1L1L2B
ACETASOL HC
ACETIC ACID W/ HYDROCORTISONE
AI3-25006
AKOS001582651
Acticort
Acticort (TN)
Aeroseb HC
Aeroseb-HC
Ala-Cort
Ala-Scalp
Alacort
Algicirtis
Alphaderm
Amberin
Anflam
Anti-inflammatory hormone
Anucort
Anucort-HC
Anusol HC
Anusol HC (TN)
Aquacort
Aquanil HC
B48448A1-24BA-47CA-8D9E-43E5BC949386
BPBio1_000544
BRD-K93568044-001-03-1
BSPBio_000494
Balneol-hc
Barseb HC
Basan-Corti
Beta-hc
Bio-0648
C00735
C21H30O5
CCRIS 5854
CHEBI:17650
CHEMBL389621
CID5754
COR-OTICIN
CPD000653523
CaldeCORT Spray
Cetacort
Chronocort
Clear aid
Cleiton
Cobadex
Colocort
Colocort (TN)
Compound F
Compound F (kendall)
Cor-Tar-Quin
Corhydron
Cort-Dome
Cort-Quin
Cortanal
Cortef
Cortef (TN)
Cortenema
Cortesal
Corticreme
Cortifair
Cortifan
Cortifoam
Cortiment
Cortisol
Cortisol alcohol
Cortisol, Hydrocortisone
Cortisolonum
Cortisporin
Cortisporin Otico
Cortispray
Cortizol
Cortolotion
Cortonema
Cortoxide
Cortril
Cremesone
Cremicort-H
Cutisol
Cyclodextrin-encapsulated hydrocortisone
D00088
DB00741
DB07886
Delacort
Derm-Aid
Dermacort
Dermaspray
Dermil
Dermocortal
Dermolate
Dihydrocostisone
Dioderm
Dome-cort
Domolene-HC
Drotic
DuoCort
EINECS 200-020-1
EU-0100594
Ef corlin
Efcorbin
Efcortelan
Efcortelin
Eldecort
Eldercort
Epicort
Epicortisol
Epiderm H
Esiderm H
Evacort
Ficortril
Fiocortril
Flexicort
Foille Insetti
Genacort
Genacort (lotion)
Glycort
Gyno-Cortisone
H 4001
H-Cort
H0135_SIGMA
H0396_SIGMA
H0888_SIGMA
H3160_SIGMA
H4001_SIGMA
H6909_SIGMA
HC
HC #1
 
HC #4
HC (HYDROCORTISONE)
HMS1569I16
HMS2090M04
HSDB 3339
HYDROCORTISONE AND ACETIC ACID
HYDROCORTISONE IN ABSORBASE
Heb Cort
Heb-Cort
Hi-cor
Hidalone
Hidro-Colisona
Hidrocortisona
Hidrocortisona [INN-Spanish]
Hycort
Hycortol
Hycortole
Hydracort
Hydrasson
Hydro-Adreson
Hydro-Colisona
Hydro-RX
Hydro-colisona
Hydrocort
Hydrocortal
Hydrocorticosterone
Hydrocortisone
Hydrocortisone (JP15/USP/INN)
Hydrocortisone Acetate
Hydrocortisone Base
Hydrocortisone Butyrate
Hydrocortisone Sodium Phosphate
Hydrocortisone Valerate
Hydrocortisone [INN:BAN:JAN]
Hydrocortisone alcohol
Hydrocortisone base
Hydrocortisone free alcohol
Hydrocortisone solution
Hydrocortisone-Water Soluble
Hydrocortisonum
Hydrocortisonum [INN-Latin]
Hydrocortistab
Hydrocortisyl
Hydrocortone
Hydroskin
Hydroxycortisone
Hysone
Hytisone
Hytone
Hytone (TN)
Hytone lotion
Idrocortisone
Idrocortisone [DCIT]
Incortin-H
Incortin-hydrogen
Kendall'S compound F
Kendall's compound F
Komed HC
Kyypakkaus
LMST02030001
LS-7439
Lacticare HC
Lacticare-HC
Lactisona
Lopac0_000594
Lubricort
MLS000069609
MLS001148103
MLS002207135
MLS002222189
Maintasone
Medicort
Meusicort
Mildison
Milliderm
MolPort-001-794-637
NCGC00022848-06
NCGC00022848-07
NCGC00022848-09
NCGC00022848-12
NCI60_000118
NSC 10483
NSC-10483
NSC10483
Neo-Cort-Dome
Neo-Cortef
Neosporin-H Ear
Nogenic HC
Nutracort
Nystaform-HC
ORLEX HC
Optef
Otalgine
Otic-Neo-Cort-Dome
Otobiotic
Otocort
Otosone-F
Pediotic Suspension
Penecort
Permicort
Polcort H
Preparation H Hydrocortisone Cream
Prepcort
Prestwick0_000447
Prestwick1_000447
Prestwick2_000447
Prestwick3_000447
Prestwick_265
Prevex HC
Proctocort
Proctofoam
Proctozone HC
Protocort
Racet
Rectasol-HC
Rectoid
Reichstein'S substance M
Reichstein's substance M
Remederm HC
S1696_Selleck
SAM002264617
SMP1_000156
SMR000059022
SMR000653523
SPBio_002433
Sanatison
Scalp-Cort
Scalpicin Capilar
Schericur
Scheroson F
Sigmacort
Signef
Stie-cort
Stiefcorcil
Synacort
Systral Hydrocort
Tarcortin
Texacort
Texacort lotion 25
Timocort
Topicort
Transderma H
Traumaide
UNII-WI4X0X7BPJ
UPCMLD-DP133
UPCMLD-DP133:001
Uniderm
Vioform-Hydrocortisone
VoSol HC
Vytone
Zenoxone
[3H]cortisol
component of Lubricort
component of Neo-Cort-Dome
component of Otalgine
hydrocortisone
12
PhenylephrineapprovedPhase 4, Phase 244059-42-76041
Synonyms:
(-)-m-Hydroxy-alpha-(methylaminomethyl)benzyl alcohol
(-)-m-Hydroxy-α-(methylaminomethyl)benzyl alcohol
(R)-2-Hydroxy-2-(3-hydroxyphenyl)-N-methylethylamine
(R)-3-Hydroxy-alpha-((methylamino)methyl)benzenemethanol
1416-03-1
3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol
59-42-7
61-76-7 (hydrochloride)
AC1L1LO9
AC1Q40UF
AI3-02402
AK-Dilate
AK-Nefrin
Adrianol
Ah-Chew
Ak-Dilate
Ak-Nefrin
Ak-dilate
Ak-nefrin
Alcon Efrin
Alcon efrin
Alconefrin Nasal Drops 12
Alconefrin Nasal Drops 25
Alconefrin Nasal Drops 50
Alconefrin Nasal Spray 25
BIDD:GT0157
BSPBio_002420
Benzenemethanol, 3-hydroxy-alpha-((methylamino)methyl)-, (R)- (9CI)
Biomydrin
C07441
CCRIS 8464
CHEBI:8093
CHEMBL1215
CID6041
Cyclomydril
D08365
DB00388
Dilatair
Dimetane
Dionephrine
DivK1c_000597
Doktors
Duration
EINECS 200-424-8
EINECS 215-810-1
Fenilefrina
Fenilefrina [INN-Spanish]
HSDB 3383
I-Phrine
IDI1_000597
Isophrim
Isophrin
Isopto Frin
KBio1_000597
KBio2_001581
KBio2_004149
KBio2_006717
KBio3_001640
KBioGR_001313
KBioSS_001581
L-Phenylephedrine
L-Phenylephrine
LS-43027
Lopac-P-6126
Lopac0_000920
M-Methylaminoethanolphenol
M-Oxedrine
M-Sympathol
M-Sympatol
M-Synephrine
 
Mesaton
Mesatone
Mesatonum
Metaoxedrin
Metaoxedrine
Metaoxedrinum
Metasympatol
Metasynephrine
Metsatonum
Mezaton
Minims Phenylephrine
MolPort-001-792-191
Mydfrin
NCGC00015825-01
NCGC00015825-02
NCGC00024257-03
NCGC00024257-05
NCGC00024257-06
NINDS_000597
Neo-Synephrine
Neo-Synephrine Nasal Drops
Neo-Synephrine Nasal Jelly
Neo-Synephrine Nasal Spray
Neo-Synephrine Pediatric Nasal Drops
Neofrin
Neophryn
Neosynephrine
Nostril
Nostril Spray Pump
Nostril Spray Pump Mild
Ocu-Phrin Sterile Eye Drops
Ocu-Phrin Sterile Ophthalmic Solution
Ocugestrin
P0395
PDSP1_001108
PDSP2_001092
Phenoptic
Phenylephrine
Phenylephrine (INN)
Phenylephrine Minims
Phenylephrine Minims (TN)
Phenylephrine [INN:BAN]
Phenylephrinum
Phenylephrinum [INN-Latin]
Prefrin
Prefrin Liquifilm
Pyracort D
R(-)-Mezaton
R(-)-Phenylephrine
Relief Eye Drops for Red Eyes
Rhinall
SPBio_001280
Spectrum2_001280
Spectrum3_000770
Spectrum4_000967
Spectrum5_001411
Spectrum_001101
Spersaphrine
Tannins, compds. with (R)-3-hydroxy-alpha-((methylamino)methyl)benzenemethanol
UNII-1WS297W6MV
Vicks Sinex
Visadron
l-(3-Hydroxyphenyl)-N-methylethanolamine
l-1-(m-Hydroxyphenyl)-2-methylaminoethanol
l-alpha-Hydroxy-beta-methylamino-3-hydroxy-L-ethylbenzene
l-m-Hydroxy-alpha-((methylamino)methyl)benzyl alcohol
m-Methylaminoethanolphenol
m-Oxedrine
m-Sympathol
m-Sympatol
m-Synephrine
phenylephrine
13
EphedrineapprovedPhase 4, Phase 2606299-42-39294
Synonyms:
( )-Pseudoephedrine
(+)-Ephedrin
(+)-Ephedrine
(+)-Pseudoephedrine
(+)-psi-Ephedrine
(+)-threo-Ephedrine
(+-)-Ephedrine
(-)-Ephedrine
(-)-Pseudoephedrine
(-)-psi-Ephedrine
(-)-threo-Ephedrine
(1R,2R)-Ephedrine
(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane
(1S,2R)-Ephedrine
(L)-EPHEDRINE
--EPHEDRINE
1-EPHEDRINE
1-Sedrin
134910_ALDRICH
287636_ALDRICH
287644_ALDRICH
299-42-3
304-87-0
30987-59-8
321-96-0
321-97-1
321-98-2
37577-31-4
38732-95-5
45261_FLUKA
4607-45-8
50-98-6
50906-05-3
53214-57-6
649031_ALDRICH
6912-63-6
7009-81-6
90-82-4
968-63-8
AC-20231
AC-20292
AC1L1JGK
AC1L1NUA
AC1L1RFA
AC1L1SR1
AC1L1T31
AC1L1Y3M
AC1O8JUO
AC1Q3XJE
AC1Q3XJM
AC1Q3XJN
AC1Q59F5
AC1Q7701
AI3-02761
AKOS000268842
AR-1A0126
AR-1I7143
Acunaso
Acunaso (TN)
Afrinol
Ambap299-42-3
BIDD:GT0817
BRN 3197916
BRN 4231286
BSPBio_001946
BSPBio_001968
BSPBio_003261
Benylin Decongestant
Besan
Biophedrin
C01575
C02765
C10H15NO
CHEBI:15407
CHEBI:51209
CHEMBL1590
CHEMBL211456
CHEMBL357080
CID11972440
CID5032
CID62946
CID6710657
CID7028
CID8650
CID9294
CID9457
CPD-9954
CPDD 0049
Cenafed
D00124
D08449
DB00852
DB01364
Decofed
DivK1c_000181
DivK1c_000451
DivK1c_000461
Drixoral N.D.
EINECS 202-017-0
EINECS 202-018-6
EINECS 206-080-5
EINECS 206-292-8
EINECS 206-293-3
Eciphin
Efedrin
Efidac/24
Eltor 120
Ephedral
Ephedremal
Ephedrin
Ephedrine
Ephedrine (TN)
Ephedrine (USP)
Ephedrine [USAN:BAN]
Ephedrine l-form
Ephedrital
Ephedrol
Ephedrosan
Ephedrotal
Ephedsol
Ephendronal
Ephoxamin
Fedrin
Genaphed
HSDB 3072
HSDB 3177
I-Sedrin
I01-3584
I01-8925
I01-8928
 
IDI1_000181
IDI1_000451
IDI1_000461
Isoephedrine
Jsp005664
KBio1_000181
KBio1_000451
KBio1_000461
KBio2_001358
KBio2_001500
KBio2_003926
KBio2_004068
KBio2_006494
KBio2_006636
KBio3_001188
KBio3_001446
KBio3_002762
KBioGR_001013
KBioGR_001763
KBioSS_001358
KBioSS_001500
KST-1A9168
Kratedyn
L(+)-psi-Ephedrine
L(-)-Ephedrine
L-(+)-Ephedrine
L-(-)-Ephedrine
L-Ephedrine
L-erythro-2-(Methylamino)-1-phenylpropan-1-ol
L000968
LS-125921
LS-125922
LS-43083
LS-63961
LS-63962
LS-63963
LS-63964
Lexofedrin
Lopac-E-3250
Lopac0_000501
MLS000069657
Manadrin
Mandrin
Maxenal
MolPort-001-684-474
MolPort-001-684-477
MolPort-001-684-478
MolPort-001-684-479
MolPort-001-769-085
Myfedrine
NCGC00015408-01
NCGC00015408-02
NCGC00162174-01
NCGC00178180-01
NCGC00178889-01
NCI-C55652
NCI60_002955
NINDS_000181
NINDS_000451
NINDS_000461
NSC 165609
NSC 170951
NSC 8971
NSC165609
NSC170951
NSC8971
Nasol
Neodurasina
Neodurasina (TN)
Oprea1_287330
PDSP1_000168
PDSP1_001106
PDSP1_001343
PDSP1_001345
PDSP1_001346
PDSP1_001347
PDSP2_000167
PDSP2_001090
PDSP2_001327
PDSP2_001329
PDSP2_001330
PDSP2_001331
PSEUDOEPHEDRINE
Pedia Care
Pseudo
Pseudo 60's
Pseudo-12
Pseudoefedrina
Pseudoephedrine (D)
Pseudoephedrinum
Psi-ephedrin
Psi-ephedrine
Robidrine
SMR000059174
SPBio_000214
SPBio_001365
SPBio_001377
ST023802
STK367993
STOCK1N-42675
Sanedrine
Spectrum2_000137
Spectrum2_001303
Spectrum2_001309
Spectrum3_000414
Spectrum3_000563
Spectrum3_001771
Spectrum4_000497
Spectrum4_001162
Spectrum5_000650
Spectrum5_000879
Spectrum5_001106
Spectrum_000878
Spectrum_001020
Sudafed
Sudafed Decongestant
UNII-03VRY66076
UNII-7CUC9DDI9F
UNII-GN83C131XS
Vencipon
WLN: QYR & Y1 & M1
WLN: QYR&Y1&M1
Zephrol
d-Ephedrine
d-Isoephedrine
d-Pseudoephedrine
d-psi-Ephedrine
l-Ephedrine
l-Pseudoephedrine
racephedrine
trans-Ephedrine
14
PseudoephedrineapprovedPhase 4, Phase 260690-82-47028
Synonyms:
( )-Pseudoephedrine
(+) threo-2-(methylamino)-1-phenyl-1-propanol
(+)-(1S,2S)-Pseudoephedrine
(+)-Pseudoephedrine
(+)-psi-Ephedrine
(+)-threo-Ephedrine
(1S,2S)-(+)-Pseudoephedrine
(1S,2S)-2-(methylamino)-1-phenylpropan-1-ol
(1S,2S)-2-Methylamino-1-phenyl-1-propanol
(1S,2S)-Pseudoephedrine
(1S,2S)-Pseudoephedrine, polymer-bound
1-Ephedrine
2-(Methylamino)-1-phenyl-1-propanol
287636_ALDRICH
304-87-0
30987-59-8
37577-31-4
649031_ALDRICH
90-82-4
AC-20292
AC1L1NUA
Acunaso
Acunaso (TN)
Afrinol
BIDD:GT0817
BRD-K84175871-003-02-2
BSPBio_003261
Balminil Decongestant Syrup
Benylin Decongestant
Benzenemethanol, alpha-((1S)-1-(methylamino)ethyl)-, (alpha-S)- (9CI)
Besan
C02765
C10H15NO
CHEBI:51209
CHEMBL1590
CID7028
CPD-9954
Cenafed
D-Isoephedrine
D-Pseudoephedrine
D-Pseudoephedrine base
D-Psi-2-Methylamino-1-phenyl-1-propanol
D-Psi-Ephedrine
D08449
DB00852
Decofed
Dimetapp Decongestant
Dimetapp Decongestant Pediatric Drops
DivK1c_000451
Drixoral N.D.
Drixoral Nasal Decongestant
EINECS 202-018-6
Efidac 24 Pseudoephedrine Hcl
Efidac/24
Eltor 120
Ephedrine
Genaphed
HSDB 3177
I01-8928
IDI1_000451
Isoephedrine
KBio1_000451
 
KBio2_001358
KBio2_003926
KBio2_006494
KBio3_002762
KBioGR_001763
KBioSS_001358
L(+)-Psi-Ephedrine
L(+)-psi-Ephedrine
L-(+)-Pseudoephedrine
LS-125922
Lopac-E-3250
Maxenal
MolPort-001-684-474
Myfedrine
NCGC00015408-01
NCGC00178180-01
NCI60_002955
NINDS_000451
Neodurasina
Neodurasina (TN)
Novafed
PDSP1_001347
PSEUDOEPHEDRINE
Pedia Care
Pseudo
Pseudo 60's
Pseudo-12
Pseudoefedrina
Pseudoefedrina [INN-Spanish]
Pseudoephedrine
Pseudoephedrine (D)
Pseudoephedrine (INN)
Pseudoephedrine D-form
Pseudoephedrine Ephedrine
Pseudoephedrine [INN:BAN]
Pseudoephedrine d-form
Pseudoephedrinum
Pseudoephedrinum [INN-Latin]
Psi-ephedrin
Psi-ephedrine
Robidrine
SPBio_001365
STOCK1N-42675
Spectrum2_001303
Spectrum3_001771
Spectrum4_001162
Spectrum5_000650
Spectrum_000878
Sudafed
Sudafed Decongestant
Sudafed Decongestant 12 Hour
Sudafed Decongestant Extra Strength
Triaminic AM Decongestant Formula
Triaminic Infant Oral Decongestant Drops
UNII-7CUC9DDI9F
alpha-(1-(Methylamino)ethyl)benzyl alcohol
d-Isoephedrine
d-Pseudoephedrine
d-psi-2-Methylamino-1-phenyl-1-propanol
d-psi-Ephedrine
pseudoéphédrine
trans-Ephedrine
ψ-ephedrine
15
Dexmedetomidineapproved, vet_approvedPhase 454076631-46-4, 113775-47-668602, 5311068, 56032
Synonyms:
(+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole
(+)-4-((S)-alpha,2,3-trimethylbenzyl)imidazole
(+)-medetomidine
(S)-medetomidine
113775-47-6
4-[(1S)-1-(2,3-Dimethylphenyl)ethyl]-1H-imidazole
4-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole
5-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole
AC1NSJXT
C07450
CHEBI:4466
CHEMBL778
CID5311068
D00514
DEXMEDETOMIDINE
 
Dexdor (T)
Dexmedetomidin
Dexmedetomidina
Dexmedetomidine
Dexmedetomidine (USAN/INN)
Dexmedetomidinum
Dexmédétomidine
MPV 1440
MPV-1440
Medetomidina [Spanish]
Medetomidine
Medetomidinum [Latin]
NCGC00025347-01
PRECEDEX
Precedex (TN)
Tocris-2023
ZINC04632106
16
MetolazoneapprovedPhase 4, Phase 11417560-51-94170
Synonyms:
17560-51-9
2-Methyl-3-O-tolyl-6-sulfamyl-7-chloro-1,2,3,4-tetrahydro-4-quinazolinone
2-Methyl-3-o-tolyl-6-sulfamyl-7-chloro-1,2,3,4-tetrahydro-4-quinazolinone
5-25-09-00212 (Beilstein Handbook Reference)
7-Chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-6-quinazolinesulfonamide
7-Chloro-1,2,3,4-tetrahydro-2-methyl-4-oxo-3-O-tolyl-6-quinazolinesulfonamide
7-Chloro-1,2,3,4-tetrahydro-2-methyl-4-oxo-3-o-tolyl-6-quinazolinesulfonamide
7-chloro-2-methyl-3-(2-methylphenyl)-4-oxo-1,2-dihydroquinazoline-6-sulfonamide
AB00052055
AC1L1HKJ
BPBio1_000138
BRD-A61793559-001-05-7
BRN 0965506
BSPBio_000124
BSPBio_002422
CHEMBL878
CID4170
D00431
DB00524
Diulo
DivK1c_000275
EINECS 241-539-3
HMS1568G06
HMS1922L16
HMS2093P14
HMS500N17
HSDB 3367
IDI1_000275
KBio1_000275
KBio2_000936
KBio2_003504
KBio2_006072
KBioGR_000897
KBioSS_000936
LS-140226
M1195_SIGMA
MLS002153316
MLS002154200
Metalazone
Metalozone
Metenix
 
Metolazon
Metolazona
Metolazona [INN-Spanish]
Metolazone (JAN/USP/INN)
Metolazone [USAN:BAN:INN:JAN]
Metolazonum
Metolazonum [INN-Latin]
Microx
MolPort-003-666-780
Mykrox
Mykrox, Zaroxolyn, Diulo, Metolazone
Métolazone
NCGC00093985-01
NCGC00093985-02
NCGC00093985-03
NCGC00093985-04
NCGC00093985-05
NCGC00093985-06
NCGC00093985-08
NINDS_000275
Oldren
Prestwick0_000112
Prestwick1_000112
Prestwick2_000112
Prestwick3_000112
Prestwick_333
S1610_Selleck
SMR001230730
SPBio_001842
SPBio_002063
SPECTRUM2300325
SR 720-22
SR-720-22
Spectrum2_001741
Spectrum4_000229
Spectrum5_001237
Spectrum_000456
UNII-TZ7V40X7VX
Xuret
Zaroxolyn
Zaroxolyn (TN)
metolazone
17tannic acidapproved, NutraceuticalPhase 4, Phase 21892
18
butyric acidexperimentalPhase 4, Phase 3363107-92-6264
Synonyms:
1-Butanoate
1-Butanoic acid
1-Butyrate
1-Butyric acid
1-Propanecarboxylate
1-Propanecarboxylic acid
Butanate
Butanic acid
Butanoate
Butanoic acid
Buttersaeure
Butyrate
 
Butyric acid
Ethylacetate
Ethylacetic acid
Honey robber
Kyselina maselna
N-Butanoate
N-Butanoic acid
N-Butyrate
N-Butyric acid
Propanecarboxylate
Propanecarboxylic acid
Propylformate
Propylformic acid
19
SynephrineexperimentalPhase 441994-07-5, 94-07-57172
Synonyms:
(+)-Synephrine
(+)-[(methylamino)methyl]-Benzenemethano
(+)-p-Synephrine
(±)-Synephrine
Analeptin
Oxedrine
 
Parasympatol
Simpalon
Simpatol
Sympaethamin
Sympaethamine
Sympatol
Synephrine
p-synephrine
20Sodium Potassium Chloride Symporter InhibitorsPhase 4, Phase 3, Phase 2, Phase 1174
21Protective AgentsPhase 4, Phase 3, Phase 2, Phase 17190
22Natriuretic AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 11645
23VasopressinsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 1286
24OxytocicsPhase 4, Phase 2, Phase 1, Early Phase 1660
25Deamino Arginine VasopressinPhase 4, Phase 3, Phase 2, Phase 172
26CoagulantsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 11428
27AnalgesicsPhase 4, Phase 3, Phase 2, Phase 111287
28Anti-Inflammatory AgentsPhase 4, Phase 3, Phase 2, Phase 110355
29HormonesPhase 4, Phase 2, Phase 3, Phase 1, Early Phase 113979
30Arginine VasopressinPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 1290
31Hypnotics and SedativesPhase 4, Phase 12485
32Liver ExtractsPhase 4, Phase 3, Phase 2, Phase 13868
33HemostaticsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 11359
34Central Nervous System DepressantsPhase 4, Phase 112806
35Analgesics, Non-NarcoticPhase 4, Phase 3, Phase 2, Phase 16260
36AnestheticsPhase 4, Phase 19001
37Autonomic AgentsPhase 4, Phase 3, Phase 2, Phase 19774
38Bronchodilator AgentsPhase 4, Phase 3, Phase 2, Phase 12856
39insulinPhase 44524
40Epinephryl boratePhase 4, Phase 3, Phase 2, Phase 1933
41Anti-Asthmatic AgentsPhase 4, Phase 3, Phase 2, Phase 13369
42Adrenergic beta-AgonistsPhase 4, Phase 3, Phase 2, Phase 11640
43Insulin, Globin ZincPhase 44523
44Vasoconstrictor AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 12027
45Adrenergic AgonistsPhase 4, Phase 3, Phase 2, Phase 12877
46Adrenergic alpha-AgonistsPhase 4, Phase 3, Phase 2, Phase 11625
47MydriaticsPhase 4, Phase 3, Phase 2, Phase 1763
48Adrenergic AgentsPhase 4, Phase 3, Phase 2, Phase 15140
49RacepinephrinePhase 4, Phase 3, Phase 2, Phase 1933
50Hypoglycemic AgentsPhase 4, Phase 2, Phase 3, Phase 15733

Interventional clinical trials:

(show top 50)    (show all 303)
idNameStatusNCT IDPhase
1Tolvaptan for Hyponatremia in Cirrhotic Patients With AscitesUnknown statusNCT01716611Phase 4
2Desmopressin for Improving Nocturnal Enuresis in Patients After Radical Cystectomy With Bladder ReconstructionUnknown statusNCT01582542Phase 4
3Normoglycemia and Neurological OutcomeUnknown statusNCT01137773Phase 4
4Effects of Desmopressin on Blood Loss and the Quality of the Surgical Field During Endoscopic Sinus SurgeryUnknown statusNCT02125188Phase 4
5Desmopressin Melt Therapy in Nocturnal Polyuria Patients: Pharmacodynamic StudyUnknown statusNCT01439997Phase 4
6Desmopressin for Bleeding Related to Low Body TemperatureUnknown statusNCT00902057Phase 4
7Effect of Samsca on Control of Hyponatremia and Extracellular Fluid in Cirrhotic Patients With AscitesUnknown statusNCT01552590Phase 4
81-deamino 8-d-arginine Vasopressin (DDAVP) in Percutaneous Ultrasound-guided Renal BiopsyCompletedNCT00748072Phase 4
9Desmopressin in the Treatment of Mixed Nocturia With Nocturnal Polyuria and Low Nocturnal Bladder CapacityCompletedNCT00902655Phase 4
10Vasopressin and Epinephrine Versus Epinephrine Alone in Cardiac ArrestCompletedNCT00127907Phase 4
11Effects on Exercise Hemodynamics of Vasopressin Blockade by Conivaptan Infusion in Heart Failure PatientsCompletedNCT01752543Phase 4
12Tolvaptan for Ascites in Cirrhotic PatientsCompletedNCT01292304Phase 4
13Effect of Tolvaptan on Mid- to Long-term Prognosis of Heart Failure PatientsCompletedNCT01439009Phase 4
14A Study of Multiple Dosing Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic HyponatremiaCompletedNCT00435591Phase 4
15Tolvaptan in Hyponatremic Cancer PatientsCompletedNCT01199198Phase 4
16Vasopressin Administration During Laparoscopic Myomectomy: a Randomized Controlled TrialCompletedNCT01393704Phase 4
17Comparison of the Effects of Cervical Vasopressin Versus no Premedication on Blood Loss During Vaginal Hysterectomy: A Randomized, Placebo Controlled TrialCompletedNCT00799292Phase 4
18Desmopressin in Cardiac SurgeryCompletedNCT00337766Phase 4
19Study of the Use of Misoprostol to Decrease Bleeding During a MyomectomyCompletedNCT01700478Phase 4
20Desmopressin Melt: Impact on Sleep and Daytime FunctioningCompletedNCT01645475Phase 4
21Effects of Tolvaptan in Healthy AdultsCompletedNCT01973140Phase 4
22Severe Aortic Stenosis and Acquired Von Willebrand´s Disease: The Impact of Desmopressin in Valve-Replacement SurgeryCompletedNCT01994330Phase 4
23Desmopressin Melt Therapy in Patients With Nocturnal Polyuria: a Pharmacokinetic/Dynamic StudyCompletedNCT01435083Phase 4
24Influence of Food-intake on Desmopressin Oral Tablets and MELT-formulationCompletedNCT01036841Phase 4
25A Study of Oral Desmopressin in Previously Untreated Children Aged 5 to 15 Years With Primary Nocturnal EnuresisCompletedNCT00245479Phase 4
26A 6-week Open Label Cross-over Study With 2 Different Daily Doses of Minirin® Oral Lyophilisate in Children and Adolescents With Primary Nocturnal Enuresis (PNE)CompletedNCT00209261Phase 4
27Effects of Vasopressors on Immune ResponseCompletedNCT02675868Phase 4
28Pilot Study of Using Copeptin to Predict Response to TolvaptanCompletedNCT01346072Phase 4
29Tolvaptan/Ultrafiltration in the Treatment of Acute Heart FailureCompletedNCT01863511Phase 4
30The Safety and Efficacy of Tolvaptan for Patients With Tricuspid Regurgitation and Right Heart Failure After Left Heart Valves ReplacementCompletedNCT02644616Phase 4
31Effect of Dexmedetomidine on Plasmatic Cortisol Response in Transsphenoidal SurgeryRecruitingNCT02549768Phase 4
32Vasoactive Drugs in Intensive Care UnitRecruitingNCT02118467Phase 4
33Aquaresis Utility for Hyponatremic Acute Heart Failure StudyRecruitingNCT02183792Phase 4
34Pharmacokinetics and Pharmacodynamics of Desmopressin Oral Lyophilisate Formulation in the Paediatric PopulationRecruitingNCT02584231Phase 4
35Tolvaptan for Advanced or Refractory Heart FailureRecruitingNCT02959411Phase 4
36Regional Tolvaptan RegistryRecruitingNCT02666651Phase 4
37Outcome and Treatment Quality Study of Tolvaptan to Treat Hyponatremia in Patients With Heart FailureRecruitingNCT02352285Phase 4
38NOrepinephrine and VasoprEssin Versus Norepinephrine aLone in Critically Ill Patients With Septic ShockActive, not recruitingNCT02454348Phase 4
39Comparison of Oral or Intravenous Thiazides vs Tolvaptan in Diuretic Resistant Decompensated Heart FailureEnrolling by invitationNCT02606253Phase 4
40Tolvaptan For Worsening Outpatient Heart Failure: Role of Copeptin In Identifying RespondersNot yet recruitingNCT02476409Phase 4
41Vasoactive Hormones and Oxygen Saturation During Apneic Events in Patients With Obstructive Sleep ApneaSuspendedNCT00438412Phase 4
42Effect of Desmopressin on the Nocturnal Micturition Frequency in Patients With Parkinson DiseaseTerminatedNCT00806468Phase 4
43Tolvaptan to Reduce Length of Stay in Hospitalized Patients With Cirrhosis and HyponatremiaTerminatedNCT01890694Phase 4
44Desmopressin as Treatment for Postoperative Bleeding After Cardiac SurgeryTerminatedNCT00885924Phase 4
45Use of Conivaptan (Vaprisol) for Hyponatremic Neuro-ICU PatientsTerminatedNCT00727090Phase 4
46Diuretic and Renal Effects of Vaprisol When Administered Along With Furosemide and Nesiritide Continuous InfusionWithdrawnNCT00806910Phase 4
47Urinary Aquaporine 2 in Patients With Syndrome of Inappropriate ADH-secretion Caused by Treatment With Antiepileptic MedicineWithdrawnNCT00298753Phase 4
48The Use of Tolvaptan to Prevent Renal Dysfunction in High Risk Patients With Heart Failure-Pilot StudyWithdrawnNCT01663662Phase 4
49Vasopressin Versus Norepinephrine for the Management of Shock After Cardiac SurgeryUnknown statusNCT01505231Phase 3
50Efficacy and Safety Study of the Tolvaptan Tablets in Patients With Non-hypovolemic Non-acute HyponatremiaUnknown statusNCT01507727Phase 2, Phase 3

Search NIH Clinical Center for Diabetes Insipidus, Neurohypophyseal


Cochrane evidence based reviews: diabetes insipidus, neurogenic

Genetic Tests for Diabetes Insipidus, Neurohypophyseal

About this section

Genetic tests related to Diabetes Insipidus, Neurohypophyseal:

id Genetic test Affiliating Genes
1 Neurohypophyseal Diabetes Insipidus27 24 AVP
2 Diabetes Insipidus, Neurohypophyseal Type27

Anatomical Context for Diabetes Insipidus, Neurohypophyseal

About this section

MalaCards organs/tissues related to Diabetes Insipidus, Neurohypophyseal:

36
Heart, Brain, Pituitary, Kidney, Liver, Lung, Bone

Publications for Diabetes Insipidus, Neurohypophyseal

About this section

Articles related to Diabetes Insipidus, Neurohypophyseal:

idTitleAuthorsYear
1
Gene symbol: AVP. Disease: Diabetes Insipidus, neurohypophyseal. (20960625)
2008
2
Gene symbol: AVP. Disease: Diabetes insipidus, neurohypophyseal. Accession #Hm0561. (17297717)
2006
3
Gene symbol: AVP. Disease: Diabetes insipidus, neurohypophyseal. Accession #Hm0559. (17297715)
2006
4
Gene symbol: AVP. Disease: Diabetes insipidus, neurohypophyseal. Accession #Hm0560. (17297716)
2006
5
Gene symbol: AVP. Disease: Diabetes insipidus, neurohypophyseal. Accession #Hm0558. (17297714)
2006

Variations for Diabetes Insipidus, Neurohypophyseal

About this section

UniProtKB/Swiss-Prot genetic disease variations for Diabetes Insipidus, Neurohypophyseal:

70 (show all 39)
id Symbol AA change Variation ID SNP ID
1AVPp.Ser17PheVAR_004980
2AVPp.Ala19ThrVAR_004981rs387906511
3AVPp.Ala19ValVAR_004982rs387906512
4AVPp.Gly45ArgVAR_004983
5AVPp.Gly48ValVAR_004984rs121964883
6AVPp.Arg51CysVAR_004985
7AVPp.Pro55LeuVAR_004986
8AVPp.Glu78GlyVAR_004988
9AVPp.Leu81ProVAR_004989
10AVPp.Gly88ArgVAR_004990
11AVPp.Gly88SerVAR_004991rs121964882
12AVPp.Cys92SerVAR_004992
13AVPp.Gly93TrpVAR_004993rs121964885
14AVPp.Gly96CysVAR_004994
15AVPp.Tyr21HisVAR_015262rs121964893
16AVPp.Pro26LeuVAR_015263rs142886338
17AVPp.Cys52ArgVAR_015264
18AVPp.Gly54ArgVAR_015265rs121964888
19AVPp.Gly54ValVAR_015266rs121964887
20AVPp.Cys59ArgVAR_015267
21AVPp.Cys59TyrVAR_015268
22AVPp.Ser87PheVAR_015269rs121964890
23AVPp.Cys92TyrVAR_015270rs121964891
24AVPp.Gly96ValVAR_015271rs121964886
25AVPp.Arg97CysVAR_015272
26AVPp.Arg97ProVAR_015273
27AVPp.Cys98GlyVAR_015274
28AVPp.Cys104PheVAR_015275
29AVPp.Cys105ArgVAR_015276
30AVPp.Cys116GlyVAR_015277rs74315383
31AVPp.Cys116ArgVAR_015278
32AVPp.Cys105TyrVAR_015279
33AVPp.Val67AlaVAR_019273rs28934878
34AVPp.Gly96AspVAR_019274
35AVPp.Cys104GlyVAR_019275
36AVPp.Cys116TrpVAR_019276
37AVPp.Cys58PheVAR_029997
38AVPp.Cys98SerVAR_029998
39AVPp.Ala99ProVAR_029999

Clinvar genetic disease variations for Diabetes Insipidus, Neurohypophyseal:

5 (show all 19)
id Gene Variation Type Significance SNP ID Assembly Location
1AVPNM_000490.4(AVP): c.262G> A (p.Gly88Ser)SNVPathogenicrs121964882GRCh37Chr 20, 3063683: 3063683
2AVPNM_000490.4(AVP): c.143G> T (p.Gly48Val)SNVPathogenicrs121964883GRCh37Chr 20, 3063802: 3063802
3AVPNM_000490.4(AVP): c.55G> A (p.Ala19Thr)SNVPathogenicrs387906511GRCh37Chr 20, 3065266: 3065266
4AVPAVP, 3-BP DEL, NT1824deletionPathogenicChr na, -1: -1
5AVPNM_000490.4(AVP): c.294C> A (p.Cys98Ter)SNVPathogenicrs121964884GRCh37Chr 20, 3063651: 3063651
6AVPNM_000490.4(AVP): c.277G> T (p.Gly93Trp)SNVPathogenicrs121964885GRCh37Chr 20, 3063668: 3063668
7AVPAVP, 1-BP DEL, 227GdeletionPathogenicChr na, -1: -1
8AVPNM_000490.4(AVP): c.287G> T (p.Gly96Val)SNVPathogenicrs121964886GRCh37Chr 20, 3063658: 3063658
9AVPNM_000490.4(AVP): c.56C> T (p.Ala19Val)SNVPathogenicrs387906512GRCh37Chr 20, 3065265: 3065265
10AVPNM_000490.4(AVP): c.161G> T (p.Gly54Val)SNVPathogenicrs121964887GRCh37Chr 20, 3063784: 3063784
11AVPNM_000490.4(AVP): c.160G> C (p.Gly54Arg)SNVPathogenicrs121964888GRCh37Chr 20, 3063785: 3063785
12AVPNM_000490.4(AVP): c.337G> T (p.Glu113Ter)SNVPathogenicrs121964889GRCh37Chr 20, 3063434: 3063434
13AVPNM_000490.4(AVP): c.260C> T (p.Ser87Phe)SNVPathogenicrs121964890GRCh37Chr 20, 3063685: 3063685
14AVPNM_000490.4(AVP): c.275G> A (p.Cys92Tyr)SNVPathogenicrs121964891GRCh37Chr 20, 3063670: 3063670
15AVPNM_000490.4(AVP): c.200T> C (p.Val67Ala)SNVPathogenicrs28934878GRCh37Chr 20, 3063745: 3063745
16AVPNM_000490.4(AVP): c.346T> G (p.Cys116Gly)SNVPathogenicrs74315383GRCh37Chr 20, 3063425: 3063425
17AVPNM_000490.4(AVP): c.61T> C (p.Tyr21His)SNVPathogenicrs121964893GRCh37Chr 20, 3065260: 3065260
18AVPAVP, 3-BP DEL, PHE3DELdeletionPathogenicChr na, -1: -1
19AVPNM_000490.4(AVP): c.131G> T (p.Cys44Phe)SNVLikely pathogenicGRCh37Chr 20, 3063814: 3063814

Expression for genes affiliated with Diabetes Insipidus, Neurohypophyseal

About this section
Search GEO for disease gene expression data for Diabetes Insipidus, Neurohypophyseal.

Pathways for genes affiliated with Diabetes Insipidus, Neurohypophyseal

About this section

GO Terms for genes affiliated with Diabetes Insipidus, Neurohypophyseal

About this section

Cellular components related to Diabetes Insipidus, Neurohypophyseal according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1extracellular regionGO:00055767.7AVP, GNRH1, LNPEP, POMC, PRL

Biological processes related to Diabetes Insipidus, Neurohypophyseal according to GeneCards Suite gene sharing:

(show all 11)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of systemic arterial blood pressureGO:000308410.5AVP, AVPR2
2positive regulation of vasoconstrictionGO:004590710.5AVP, AVPR2
3excretionGO:000758810.4AQP2, AVPR2
4generation of precursor metabolites and energyGO:000609110.4AVP, POMC
5renal water homeostasisGO:000309110.1AQP2, AVP, AVPR2
6regulation of blood pressureGO:000821710.1LNPEP, POMC
7response to testosteroneGO:003357410.1AVP, GNRH1
8water transportGO:00068339.8AQP2, AVP
9female pregnancyGO:00075659.3GNRH1, LNPEP, PRL
10cell-cell signalingGO:00072678.9AVP, GNRH1, LNPEP, POMC
11signal transductionGO:00071658.5AVP, GNRH1, LNPEP, POMC

Molecular functions related to Diabetes Insipidus, Neurohypophyseal according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1neuropeptide hormone activityGO:000518410.1AVP, POMC
2peptide bindingGO:00422779.4AVPR2, LNPEP
3hormone activityGO:00051799.2GNRH1, POMC, PRL

Sources for Diabetes Insipidus, Neurohypophyseal

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet